AzurRx BioPharma, Inc. (AZRX) has 6 open-market insider trades by 5 insiders since 2017. The most active filer is Edmund Burke Ross Jr., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Edmund Burke Ross Jr. | 10% Owner | — | 2 | $689K | 2019-02-14 |
| Matthew Balk | 10% Owner | — | 1 | $510K | 2017-06-30 |
| Johan M. Spoor | CEOPres | — | 1 | $100K | 2018-12-28 |
| Maged Shenouda | CFO | — | 1 | $26K | 2018-12-28 |
| Charles J. Casamento | Dir | — | 1 | $13K | 2020-03-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Maged Shenouda | CFO | Buy | $26K | 2018-12-28 |
| Johan M. Spoor | CEO & President | Buy | $100K | 2018-12-28 |
| Charles J. Casamento | Director | Buy | $13K | 2018-12-28 |
| Edmund Burke Ross Jr. | 10% Owner | Buy | $239K | 2018-05-02 |
| Matthew Balk | 10% Owner | Sell | $510K | 2017-06-30 |
| Edmund Burke Ross Jr. | 10% Owner | Buy | $450K |
Companies that share insiders with AZRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-06-05 |